NCT05261334 is a NA clinical trial of contour augmentation in Bone Loss, sponsored by Iman Abd-ElWahab Radi, PhD.

Who is sponsoring NCT05261334?

NCT05261334 is sponsored by Iman Abd-ElWahab Radi, PhD.

What drugs are being tested in NCT05261334?

Interventions in NCT05261334: contour augmentation.

What condition does NCT05261334 study?

NCT05261334 studies Bone Loss, Bone Resorption.

Is NCT05261334 still recruiting?

NCT05261334 is currently status unknown. Last updated 25 March 2022.

Last reviewed 2022-03-25 · How we verify

NCT05261334

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Socket Shield Technique Versus Early Implant Placement With Contour Augmentation

Status unknown NA Last updated 25 March 2022

What this trial tests

NA trial testing contour augmentation in Bone Loss in 20 participants. Status unknown.

Timeline

31 March 2022

Primary endpoint
31 March 2023

1 September 2023

Quick facts

Lead sponsor	Iman Abd-ElWahab Radi, PhD
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	31 March 2022
Primary completion	31 March 2023
Estimated completion	1 September 2023
Sites	1 location across Egypt

Drugs / interventions tested

contour augmentation

Conditions studied

Bone Loss — all drugs for Bone Loss →
Bone Resorption — all drugs for Bone Resorption →

Sponsor

Iman Abd-ElWahab Radi, PhD

Who can join

Adults 18 to 60, any sex, with Bone Loss or Bone Resorption. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

comparing socket shield technique with early implant placement with contour augmentation in preserving the bone contour

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bone Loss

Currently open trials in the same condition.

NCT07156110 — Prosthetic Modality and MBL · NA · recruiting
NCT07196943 — Prospective Outcomes of Guided Equator Overdentures · recruiting
NCT06629961 — Impact of Transepithelial Abutment Connection and Disconnection in Dental Implants · NA · recruiting
NCT06527664 — Innovative Technologies for Salvage Procedures of Failed Treatments of Osteoarthritis: Biomimetics Solutions (CustomPN) · recruiting
NCT04112992 — An International, Multicenter, Prospective Registry on Post-traumatic Long Bones Defects · recruiting

Other Iman Abd-ElWahab Radi, PhD trials

Trials by the same sponsor.

NCT04694209 — Patient Satisfaction and OHRQoL In Removable Versus Fixed Implant Prostheses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05261334 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Iman Abd-ElWahab Radi, PhD
Last refreshed: 25 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05261334.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing